Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study
Charles T-C Lee1, I-Chieh Mao, Ching-Hsiung Lin
1Department of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan.
European Journal of Clinical Investigation
|September 14, 2013
Summary
Chronic obstructive pulmonary disease (COPD) significantly increases the risk of developing type 2 diabetes. This study highlights the need for vigilant monitoring of blood sugar in COPD patients to prevent diabetes.
Area of Science:
- Medical Research
- Epidemiology
- Pulmonology
Background:
- Type 2 diabetes mellitus (DM) is a major global health concern.
- Chronic obstructive pulmonary disease (COPD) is a prevalent condition with significant morbidity and mortality.
- The relationship between COPD and type 2 diabetes risk, particularly in Asian populations, requires further investigation.
Purpose of the Study:
- To investigate if chronic obstructive pulmonary disease (COPD) is a risk factor for type 2 diabetes.
- To identify independent risk factors for type 2 diabetes in patients with COPD.
Main Methods:
- Utilized Taiwan's National Health Insurance Research Database for data collection.
- Included 16,088 patients: 8044 with COPD and 8044 matched controls.
- Employed Cox proportional hazard regression for risk factor analysis.
Main Results:
- Patients with COPD exhibited a significantly higher incidence rate of type 2 diabetes (P < 0.001).
- COPD remained a significant risk factor for type 2 diabetes (HR: 1.41) after adjusting for multiple confounding factors.
- Hypertension (HR: 1.55) and hypertriglyceridemia (HR: 1.48) were identified as key risk factors for type 2 diabetes within the COPD cohort.
Conclusions:
- COPD patients face an elevated risk of developing type 2 diabetes, independent of other health conditions and demographic factors.
- Routine screening for dysglycemia should be integrated into the management of patients with COPD.
- This research underscores the importance of managing comorbidities in COPD to mitigate diabetes risk.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation